Search results
French health groups put forward proposals to limit the damage of worsening drug shortages
Euronews via Yahoo News· 4 hours agoPharmaceutical companies’ lack of transparency leads to rising drug prices and less control over...
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks via Yahoo Finance· 3 hours agoAlternatives SPDR S&P Pharmaceuticals ETF carries a Zacks ETF Rank of 3 (Hold), which is based on...
Ligand Pharmaceuticals exec sells over $1.4m in stock By Investing.com
Investing.com· 14 hours agoIn a recent move, Matthew E. Korenberg, the President and Chief Operating Officer of Ligand ...
HKTDC Kicks Off Third International Healthcare Week
NewMediaWire via Yahoo Finance· 58 minutes agoAsia Summit on Global Health and Medical Fair commence today Over 80 healthcare experts discuss forward-looking topics at Asia Summit on Global Health,...
Newswise Expert | Stephen Crystal, Institute for Health, Health Care Policy and Aging Research at...
Newswise· 58 minutes agoStephen Crystal (Ph. D., Harvard, 1981) is a Research Professor and Chair of the AIDS Policy Research Group at the Institute. Dr. Crystal’s research group conducts a variety of studies addressing ...
UN Agency Authorizes Second Vaccine Against Dengue Amid Outbreaks in the Americas
US News & World Report· 1 day agoThe World Health Organization on Wednesday authorized a second dengue vaccine, a move that could provide protection for millions worldwide against the mosquito-borne disease ...
Cardinal Health shares target cut by Argus amid contract pressures By Investing.com
Investing.com· 1 day agoCardinal Health, recognized as one of the leading distributors of pharmaceuticals in the United...
PMV Pharmaceuticals, Inc. to Post FY2025 Earnings of ($1.47) Per Share, HC Wainwright Forecasts...
ETF DAILY NEWS· 9 hours agoPMV Pharmaceuticals, Inc. (NASDAQ:PMVP – Free Report) – Research analysts at HC Wainwright issued their FY2025 earnings per share estimates for shares of PMV Pharmaceuticals ...
Xeris Pharmaceuticals target cut on Q1 results By Investing.com
Investing.com· 6 days agoOn Friday, Xeris Pharmaceuticals (NASDAQ:XERS) saw its stock price target adjusted by Piper Sandler...
Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 11 hours agoAdditional data from the Phase IIb clinical trial showed ibezapolstat, but not vancomycin, consistently preserved and allowed regrowth of key gut bacteria species believed to confer
